Shareholders Equity: The sum of preferred and common equity items.
Kronos Bio, Inc. (KRON) had Shareholders Equity of $87.58M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$9.85M |
|
$-86.08M |
|
-- |
|
$9.85M |
|
$102.73M |
|
$-92.89M |
|
$6.81M |
|
$-86.08M |
|
$-86.08M |
|
$-86.08M |
|
$-86.08M |
|
$-86.08M |
|
$-86.08M |
|
$-92.89M |
|
$-93.98M |
|
60.07M |
|
60.07M |
|
$-1.43 |
|
$-1.43 |
|
| Balance Sheet Financials | |
$115.23M |
|
$3.82M |
|
$9.13M |
|
$124.36M |
|
$15.28M |
|
-- |
|
$21.51M |
|
$36.78M |
|
$87.58M |
|
$87.58M |
|
|
Shareholders Equity |
$87.58M |
60.46M |
|
| Cash Flow Statement Financials | |
$-65.44M |
|
$85.44M |
|
$0.24M |
|
$66.35M |
|
$86.60M |
|
$20.25M |
|
$9.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-943.21% |
|
-943.21% |
|
-954.29% |
|
-874.08% |
|
-874.08% |
|
$-65.44M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-98.29% |
|
-98.29% |
|
-69.22% |
|
-98.29% |
|
$1.45 |
|
$-1.09 |
|
$-1.09 |
|